MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/advs.76905

Медицинская библиотека · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026

Crosstalk Between CTSB+ Glioblastoma Cells and S100A10+ Macrophages: A Self-Reinforcing Circuit Promotes Immune Evasion and Limits Response to Immunotherapy.

Zhang Hao, Zhang Nan, Liang Xisong, Wen Jie, Dai Ziyu, Wu Wantao, Li Shuyu, Feng Songshan, Liu Zaoqu, Xia Zhiwei, Luo Peng, Cheng Quan

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Glioblastoma (GBM) establishes a highly immunosuppressive microenvironment through intricate molecular dialogues with tumor-associated macrophages (TAMs), contributing to immunotherapy resistance.

METHODS

We integrated advanced biological network analyses with multimodal AI to identify CTSB as a key biomarker. Functional validation included GBM-macrophage co-culture systems, chromatin immunoprecipitation (ChIP), dual-luciferase reporter assays, molecular docking, and co-immunoprecipitation (Co-IP). In vivo experiments employed orthotopic (GL261 and CT-2A) and subcutaneous GBM models with lentivirus-mediated CTSB knockdown and anti-PD-1 therapy. Tumor microenvironment dynamics were assessed via in-house generated single-cell RNA sequencing and multiplex immunofluorescence.

RESULTS

Cathepsin B (CTSB) was identified as a critical driver of aggressive GBM progression and poor outcomes. Mechanistically, macrophage-derived IL-6 activates STAT3 in tumor cells, upregulating CTSB expression. Structural and Co-IP analyses revealed CTSB, secreted by tumor cells, binds the C-terminus of macrophage S100A10, reinforcing IL-6 secretion, forming a feedforward loop between CTSB+ GBM cells and S100A10+ macrophages. This loop enhances tumor growth, invasion, and immune evasion via PD-L1 upregulation. In vivo, CTSB blockade reduced TAM activation, increased CD8+ T cell infiltration, and synergized with anti-PD-1 therapy.

CONCLUSIONS

This study unveils a targetable GBM-macrophage signaling axis, proposing CTSB inhibition as a strategy to enhance immunotherapy efficacy in GBM patients.

Для цитирования: Zhang Hao, Zhang Nan, Liang Xisong, Wen Jie, Dai Ziyu, Wu Wantao, Li Shuyu, Feng Songshan, Liu Zaoqu, Xia Zhiwei, Luo Peng, Cheng Quan. Crosstalk Between CTSB+ Glioblastoma Cells and S100A10+ Macrophages: A Self-Reinforcing Circuit Promotes Immune Evasion and Limits Response to Immunotherapy.. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2026. DOI: 10.1002/advs.76905.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.